Dilsad ltd Herkiloglu

Dr. Dilsad ltd Herkiloglu


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2021 in Ginekologia Polska
Verified
Journal Article
Closed access
PDF file
DHDilsad ltd Herkiloglu
Dilsad ltd Herkiloglu
SGSefik Gokce
Sefik Gokce
Objectives: Monocyte/high density lipprotein (HDL) ratio (MHR) has been reported to be associated with obesity and polycystic ovarian syndrome (PCOS). In this study, it was aimed to evaluate whether there is a relationship between PCOS and MHR and inflammatory parameters, to investigate the relationship level of MHR and lymphocyte/monocyte ratio (LMR), which are easily accessible inflammatory and oxidative stress markers, with obese women with PCOS, and to determine the usability of MHR as a predictive marker for PCOS. Material and methods: The study included 64 PCOS-patients who were admitted to Gynecology clinics and 52 healthy women. The mean MHR (12.5 ± 4.6) in the PCOS group was significantly higher than the control group (10.4 ± 4.0) (p = 0.01). In the examination performed by combining the groups PCOS and obesity status, the mean MHR value in the PCOS-obese group was significantly higher than all the other groups (p = 0.004). In the ROC analysis, the threshold value of 10.1 for MHR was found to have a sensitivity of 84.8% and specificity of 58.5% in determining the association between PCOS and obesity (AUC: 0.721; p < 0.001; LB: 0.628; UB: 0.814; CI 95%). Accordingly, the rate of those with MHR level of 10.1 and above was significantly higher in the PCOS group compared to the control group (67.2% vs 40.4%) (p = 0.001). In the logistic regression analysis, the determination is increased by 3,026 times (odds ratio; 1.401–6.535) in predicting the presence of PCOS in those with MHR value of 10.1 and above, and 7,576 times (Odds ratio; 2.652–21.646) in predicting the presence of PCOS + obesity. was found to be. Correlation analysis in PCOS patients revealed that the MHR value was negatively correlated with age (p = 0.001; r = –0.412), LMR (p = 0.003; r = –0.377), and total cholesterol [p = 0.018; correlation coefficient (r) = –0.302]. Conclusions: This study findings showed that MHR level is significantly related to PCOS, and especially MHR values above 10.1 may be a significant predictive marker for PCOS. Our study findings also show that an association of PCOS and obesity is a very important trigger on MHR. Objectives: Monocyte/high density lipprotein (HDL) ratio (MHR) has been reported to be associated with obesity and polycystic ovarian syndrome (PCOS). In this study, it was aimed to evaluate whether there is a relationship between PCOS and MHR and inflammatory parameters, to investigate the relationship level of MHR and lymphocyte/monocyte ratio (LMR), which are easily accessible inflammatory and oxidative stress markers, with obese women with PCOS, and to determine the usability of MHR as a predictive marker for PCOS. Material and methods: The study included 64 PCOS-patients who were admitted to Gynecology clinics and 52 healthy women. The mean MHR (12.5 ± 4.6) in the PCOS group was significantly higher than the control group (10.4 ± 4.0) (p = 0.01). In the examination performed by combining the groups PCOS and obesity status, the mean MHR value in the PCOS-obese group was significantly higher than all the other groups (p = 0.004). In the ROC analysis, the threshold value of 10.1 for MHR was found to have a sensitivity of 84.8% and specificity of 58.5% in determining the association between PCOS and obesity (AUC: 0.721; p < 0.001; LB: 0.628; UB: 0.814; CI 95%). Accordingly, the rate of those with MHR level of 10.1 and above was significantly higher in the PCOS group compared to the control group (67.2% vs 40.4%) (p = 0.001). In the logistic regression analysis, the determination is increased by 3,026 times (odds ratio; 1.401–6.535) in predicting the presence of PCOS in those with MHR value of 10.1 and above, and 7,576 times (Odds ratio; 2.652–21.646) in predicting the presence of PCOS + obesity. was found to be. Correlation analysis in PCOS patients revealed that the MHR value was negatively correlated with age (p = 0.001; r = –0.412), LMR (p = 0.003; r = –0.377), and total cholesterol [p = 0.018; correlation coefficient (r) = –0.302]. Conclusions: This study findings showed that MHR level is significantly related to PCOS, and especially MHR values above 10.1 may be a significant predictive marker for PCOS. Our study findings also show that an association of PCOS and obesity is a very important trigger on MHR.

1 December 2020 in Journal of Academic Research in Medicine
Verified
Journal Article
Closed access
DHDilsad ltd Herkiloglu
Dilsad ltd Herkiloglu
SGsefik gokce
sefik gokce
PGPınar Göksedef
Pınar Göksedef
CKCanan Kabaca
Canan Kabaca
GSGülhan Sağıroğlu
Gülhan Sağıroğlu

17 May 2022 in Oncology Letters
Verified
Journal Article
Open access
PDF file
DHDilsad ltd Herkiloglu
Dilsad ltd Herkiloglu
SGSefik Gokce
Sefik Gokce
EKEcmel Isik Kaygusuz
Ecmel Isik Kaygusuz
OCOzge Cevik
Ozge Cevik
While various molecular profiling methods have been described for the early diagnosis and prognostic process of endometrial cancer, the most common gynaecological cancer, the data obtained remain insufficient. The present study aimed to investigate the protein and gene expression of periostin and its role as a new biomarker in the diagnosis, treatment and prognosis of endometrial cancer. A total of 15 patients diagnosed with endometrial cancer at the Department of Pathology, Zeynep Kamil Training and Research Hospital (Istanbul, Turkey) and 15 patients who were operated on for non‑tumour‑related reasons, between December 2019 and May 2020, were included in the study. The cases diagnosed with endometrial cancer were divided into three groups: International Federation of Gynaecology and Obstetrics grades I, II and III. Pathology tumour blocks were selected for enzyme‑linked immunosorbent assay and PCR studies in which periostin gene expression and protein levels were measured, respectively. A significant increase in periostin gene expression was observed in the endometrial cancer samples compared with that in the controls (3.40±0.66 vs. 2.23±0.47). The protein level of periostin in the tissues was found to be higher in the endometrial cancer samples than that in the control group (1.59±0.31 vs. 0.94±0.22). The levels of periostin protein and gene expression detected in the endometrial cancer samples increased as the grade increased. To the best of our knowledge, the current study is the first to determine the levels of periostin protein and gene expression in endometrial cancer. The results suggested that periostin may be used as a biomarker in the determination of higher histological grade in endometrial cancer.

21 January 2021 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
DHDilsad ltd Herkiloglu
Dilsad ltd Herkiloglu
HTHabibe Ayvacı Taşan
Habibe Ayvacı Taşan
OPOya Pekin
Oya Pekin
NTNazan Tarhan
Nazan Tarhan
AKAteş Karateke
Ateş Karateke
SSSadik Sahin
Sadik Sahin
The aim was to evaluate the effectiveness of Arabin pessary use in patients with cervical insufficiency or short cervix before the 24th week of gestation and the impact of cervical examination find...

25 August 2022 in Journal of Academic Research in Medicine
Verified
Journal Article
Closed access
DHDilsad ltd Herkiloglu
Dilsad ltd Herkiloglu
SŞSadık Şahin
Sadık Şahin
CKCanan Kabaca
Canan Kabaca
CÖCansu Önal
Cansu Önal
BHBurak Hazine
Burak Hazine
MEMustafa Eroğlu
Mustafa Eroğlu

5 September 2021 in Journal of Health Sciences and Medicine
Verified
Journal Article
Open access
PDF file
SGsefik gokce
sefik gokce
DHDilsad ltd Herkiloglu
Dilsad ltd Herkiloglu
Aim: The abnormal endocrinological picture that occurs in polycystic ovary syndrome (PCOS) has been shown to affect many systems and can lead to a wide variety of complications. In our study, it was aimed to examine hormone levels, obesity, serum lipid levels and hematological parameters in adult women with PCOS. Material and Methods: The present study included 62 patients diagnosed with PCOS and 45 healthy women. Demographic data and laboratory results of all women were collected them from hospital automation system records and were analyzed. Results: The mean body mass index (BMI) (p=0.041), total cholesterol (p=0.038), triglyceride (p=0.022) and very low density lipoprotein (VLDL) cholesterol (p=0.003) levels in the patient group were significantly higher than the control group. In the patient group, anti-Müllerian hormon (AMH) (p